We all know of Botox use to reduce signs of aging. Approved in 2010 to treat migraines in adults, it’s now also being explored (as an off-label treatment) for management of pediatric migraines. 

 

In this episode, Dr. Shalini Shah, MD, MBA, the Vice-Chair for the Department of Anesthesiology & Perioperative Care and Enterprise Director of Pain Services at UC Irvine Health, shares their clinical and reseach findings, as well as the indications, caution, nuances, and protocol for use of botox in pediatric migraine. Her work on the effectiveness of Botox in pediatric patients experiencing migraines has been published in peer reviewed journals and been featured in Time Magazine and on NBC Nightly News. 

 

We discuss her landmark work, the results of her study, protocols, indications and how you can best advocate for your patients to receive the same treatment. 

 

Takeaways in This Episode

 

How Dr. Shah became interested in use of botox for pediatric headaches. Findings of her pediatric study including longitudnal data for Botox treatments in pediatric migraine.  Dosage and protocol for Botox injection for peditaric migraine (Hint: You'll be surprisedby the dosage used in kids!) FDA's stance on Botox for children's migrainesand how to navigate the approval of this off label treatment with insurance companies. Indications, contraindications and precautions when using OnabotulinumtoxinA for headaches. (Hint: No allergy butuse of caution in certain conditions is crucial!) Outcomes and patients' response after the treatment with botox; improvement in all spheres.  Strategies for preauthorization or approval by the insurance company. Dr Shah's message to healthcare professionals treating pediatric headaches

 

Links

 

Shalini Shah, MD, MBA

Connect with Dr. Shah - Twitter  Linkedin

Dr. Shah’s articles on Botox -

Effectiveness of Botox in Pediatric Migraines 

Botox for Prophylactic Treatment of Pediatric Migraines

Proactive Pain Solutions Academy

Proactive Pain Solutions

Clinicians Pain Evaluation Toolkit

Recommended Listening:
Pedia Pain Focus Episode #21: How to Counsel Your Patients on Off-Label Medication Use

Other Recommended Reading:

PREEMPT Trial 1

PREEMPT Trial 2


About the Guest

 

Shalini Shah, MD, MBA, Associate Professor is Vice-Chair for the Department of Anesthesiology & Perioperative Care and Enterprise Director of Pain Services for University of California Irvine Health. Dr. Shah completed her residency in anesthesiology from Cornell University and a combined fellowship in adult and pediatric chronic pain at Harvard Medical School. 

 

She is the founder of the Pediatric Pain Program at UC Irvine and has previously served as Associate Program Director for the Pain medicine fellowship. Dr. Shah is the recipient of the ASRA Chronic Pain Grant Award in 2017 for her landmark work in onabotulinumtoxinA (Botox) use in pediatric migraine pain. She has been featured in Time Magazine, The Doctors, NBC Nightly News, Business Insider and is a frequent guest on NPR on the topic of safe pain care options. Dr. Shah is an internationally invited lecturer and leads several industry and peer-reviewed NIH funded clinical trials in pediatric and adult pain medicine.

 

Dr. Shah currently serves as the Founding Chair, Committee of Pain Medicine at the California Society of Anesthesiologists (CSA) and President-Elect, CA Society of Interventional Pain Physicians (CALSIPP). Dr. Shah is strongly committed to pain advocacy and healthcare regulatory reform both in the state of California and nationally to improve healthcare experiences for patients. 

 

Twitter Mentions